Korean Linguistic Adaptation of Rhinitis Controlled Assessment Test

Overview

Korean linguistic adaptation of Rhinitis controlled assessment test (RCAT).

Full Title of Study: “Linguistic Adaptation of Rhinitis Control Assessment Test (RCAT) in Korean and Responsiveness to Disease Severity, Quality of Life, and Treatment in Adult Rhinitis Patients: A Multicenter Prospective Study”

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Prospective
  • Study Primary Completion Date: September 2015

Detailed Description

Check the Korean version of rhinitis controlled assessment tests, the total non-symptom scores (total nasal symptoms score, TNSS), rhinitis-related quality of life (RQLQ), rhinitis controlled degree, severity, and after study enrollment and 4 weeks treatment.

Interventions

  • Other: questionnaire
    • Check the Korean version of rhinitis controlled assessment tests, the total non-symptom scores (total nasal symptoms score, TNSS), rhinitis-related quality of life (RQLQ), rhinitis controlled degree, severity, and after study enrollment and 4 weeks treatment.

Clinical Trial Outcome Measures

Primary Measures

  • Korean linguistic adaptation of Rhinitis controlled assessment test (RCAT)
    • Time Frame: up to 4weeks
    • Check the Korean version of rhinitis controlled assessment tests

Secondary Measures

  • rhinitis-related quality of life
    • Time Frame: up to 4weeks
    • rhinitis-related quality of life (RQLQ)check up to 24 weeks

Participating in This Clinical Trial

Inclusion Criteria

1. Adults over 19 years 2. Past medical history and allergy skin test or who have been diagnosed with allergic or non-allergic rhinitis, based on serum specific immunoglobulin E . 3. People who have experienced symptoms of rhinitis within 12 months from the time of study enrollment. 4. People who have rhinitis symptoms requiring medication at the time of study enrollment. 5. People who can read and write korea language. 6. People who signed a written consent form approved by the Institutional Review Board of their respective organizations to participate in this study freely hearing to explain fully the purpose for the contents of this study prior to participation in research. Exclusion Criteria:

1. People diagnosed with Rhinitis medicamentosa. 2. People determined that bacterial or viral respiratory infection at the time of study enrollment. 3. People who have evidence of nasal infection 4. People associated anatomical abnormality that causes severe nasal congestion as deviation of nasal septum. 5. People determined that acute or chronic sinusitis according to the researchers determined. 6. In case that pregnancy test is positive, or ambiguous conclusions among female patients. 7. people deemed unsuitable for clinical trial participation due to other reasons.

Gender Eligibility: All

Minimum Age: 19 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Ajou University School of Medicine
  • Provider of Information About this Clinical Study
    • Principal Investigator: Hae-Sim Park, professor, Department of allergic interal medicine – Ajou University School of Medicine
  • Overall Official(s)
    • hae sim park, professor, Principal Investigator, Department of internal medicine

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.